Cara Therapeutics, Inc. (LON:0HTC)

Cara Therapeutics Revenue

In the year 2024, Cara Therapeutics had annual revenue of $7.14M USD, down -65.96%. Cara Therapeutics had revenue of $1.46M in the quarter ending December 31, 2024, a decrease of -51.56%.

• Revenue: $7.14M
• Revenue Growth: -65.96%
• P/S Ratio: 3.38
• Revenue / Employee: $713.70K
• Employees: 10
• Market Cap: 19.25M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.14M	-13.83M	-65.96%
Dec 31, 2023	20.97M	-20.90M	-49.92%
Dec 31, 2022	41.87M	18.84M	81.81%
Dec 31, 2021	23.03M	-112.05M	-82.95%
Dec 31, 2020	135.08M	115.20M	579.28%